Unknown

Dataset Information

0

Cdk1 participates in BRCA1-dependent S phase checkpoint control in response to DNA damage.


ABSTRACT: Cdk2 and cdk1 are individually dispensable for cell-cycle progression in cancer cell lines because they are able to compensate for one another. However, shRNA-mediated depletion of cdk1 alone or small molecule cdk1 inhibition abrogated S phase cell-cycle arrest and the phosphorylation of a subset of ATR/ATM targets after DNA damage. Loss of DNA damage-induced checkpoint control was caused by a reduction in formation of BRCA1-containing foci. Mutation of BRCA1 at S1497 and S1189/S1191 resulted in loss of cdk1-mediated phosphorylation and also compromised formation of BRCA1-containing foci. Abrogation of checkpoint control after cdk1 depletion or inhibition in non-small-cell lung cancer cells sensitized them to DNA-damaging agents. Conversely, reduced cdk1 activity caused more potent G2/M arrest in nontransformed cells and antagonized the response to subsequent DNA damage. Cdk1 inhibition may therefore selectively sensitize BRCA1-proficient cancer cells to DNA-damaging treatments by disrupting BRCA1 function.

SUBMITTER: Johnson N 

PROVIDER: S-EPMC3024055 | BioStudies | 2009-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC3905873 | BioStudies
2010-01-01 | S-EPMC2912507 | BioStudies
2014-01-01 | S-EPMC3906246 | BioStudies
2011-01-01 | S-EPMC3272302 | BioStudies
2016-01-01 | S-EPMC5224465 | BioStudies
2020-01-01 | S-EPMC7144926 | BioStudies
2019-01-01 | S-EPMC6322364 | BioStudies
1000-01-01 | S-EPMC2683695 | BioStudies
2017-01-01 | S-EPMC5432342 | BioStudies
2010-01-01 | S-EPMC2911328 | BioStudies